• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911428270
Device Problem Occlusion Within Device (1423)
Patient Problems Atherosclerosis (1728); Dyspnea (1816); Fatigue (1849); Ischemia (1942); Reocclusion (1985)
Event Date 09/01/2015
Event Type  Injury  
Manufacturer Narrative
(b)(4).Device is a combination product.Device evaluated by mfr: the complaint device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Event Description
Same case as mdr id: 2134265-2015-07327 and 2134265-2015-07328.Promus element plus clinical study it was reported that stent restenosis occurred.In (b)(6) 2012, the patient presented due to unstable angina and was referred for cardiac catheterization.Subsequently, coronary angiography and index procedure were performed.Target lesion # 1 was a de novo lesion located in the 1st diagonal with 90% stenosis and was 28mm long with a reference vessel diameter of 3.50mm.Target lesion # 1 was treated with direct stent placement using a 2.50mmx12mm promus element plus stent.Following post dilatation, residual stenosis was 0%.Target lesion # 2 was a de novo lesion located in the proximal right coronary artery (rca) with 80% stenosis and extending to distal rca with 90% stenosis and was 2.50mm long with a reference vessel diameter of 2.50mm.The 90% distal stenosis in rca was treated with pre-dilatation and placement of 2.75x28mm.The 80% proximal stenosis in rca was treated with placement of 3.50x28mm and 4.00x12.0mm promus element plus stents with 0% residual stenosis.The following day, the patient was discharged on aspirin and clopidogrel.In (b)(6) 2015, the patient presented with dyspnea and abnormal stress test and was diagnosed with coronary atherosclerosis and was hospitalized on the same day.Subsequently, the patient was referred for cardiac catheterization.The 99% stenosis located in distal rca was treated with balloon angioplasty and placement of a 3.00x32.00 mm promus premier drug eluting stent with no residual stenosis.The following day, the event was considered recovered and the patient was discharged on aspirin and clopidogrel.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that during index procedure, target lesion #2 was 80% stenosed and not 90% as previously reported.In (b)(6) 2015, the patient presented for follow up visit after recent stress test which shown the evidence of silent ischemia.Patient also had symptoms of fatigue and shortness of breath.After the placement of 3.00x32.00 mm promus premier drug eluting stent to treat the stenosis located in the mid extending to distal right coronary artery (rca), post-dilatation was performed resulting to 0% residual stenosis.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5198514
MDR Text Key30288528
Report Number2134265-2015-07326
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2015
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/21/2012
Device Model NumberH7493911428270
Device Catalogue Number39114-2827
Device Lot Number14995121
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/17/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/23/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age69 YR
-
-